Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
7.11
-0.10 (-1.39%)
Oct 29, 2024, 4:00 PM EDT - Market closed

MRVI Revenue

Maravai LifeSciences Holdings had revenue of $73.40M in the quarter ending June 30, 2024, with 6.51% growth. This brings the company's revenue in the last twelve months to $278.59M, down -48.78% year-over-year. In the year 2023, Maravai LifeSciences Holdings had annual revenue of $288.95M, down -67.28%.

Revenue (ttm)
$278.59M
Revenue Growth
-48.78%
P/S Ratio
3.40
Revenue / Employee
$428,592
Employees
650
Market Cap
1.01B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023288.95M-594.06M-67.28%
Dec 31, 2022883.00M83.76M10.48%
Dec 31, 2021799.24M515.14M181.33%
Dec 31, 2020284.10M140.96M98.48%
Dec 31, 2019143.14M19.31M15.59%
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Owens & Minor 10.53B
Avanos Medical 682.40M
Evolus 237.26M
Prothena Corporation 217.25M
Aurinia Pharmaceuticals 207.11M
Arcutis Biotherapeutics 132.06M
Mesoblast 5.90M
IGM Biosciences 2.91M
Revenue Rankings